Keyword: Nivalis Therapeutics
Juno tapped Genentech alum Sunil Agarwal as new R&D chief, Merrimack promoted Onivyde scientist Daryl Drummond as head of research, and Mitch Gold leads the newly merged Alpine.
Alpine Immune Sciences is set to merge with Nivalis Therapeutics and snag itself a stock listing in the process.
Nivalis is laying off 80% of its staff including its CEO and CMO.
Nivalis saw more than half its value wiped out after hours last night in reaction to the news that its cystic fibrosis candidate did not hit its targets, leaving its future hanging in the balance.